PPARA and asthma: Additionally, allograft rejection (ko05330), asthma (ko05310), viral myocarditis (ko05416), the PPAR signaling pathway (ko03320), and cholesterol metabolism (ko04979) were significantly enriched in the TS25 and TS45 groups (Figure 4D).